Choisissez votre pays / Select your country

Ninalia NIPT The prenatal trisomy screening test based on maternal blood sample

>99,9%
Detection rate
of Ninalia NIPT test
1
Single blood sample
10
Available from week 10
of pregnancy
5
Results available
within 5 working days
95%
Can minimize unnecessary invasive sampling by 95%

NIPT

Non-Invasive Prenatal Testing for trisomies 13, 18 and 21

Non-Invasive Prenatal screening Test is an innovative genetic test for pregnant women at risk of foetal Down syndrome (trisomy 21), Edwards’ syndrome (trisomy 18), and Patau syndrome (trisomy 13).
Now, this test also makes it possible to screen for other rarer chromosome abnormalities: autosomal abnormalities, deletions and duplications greater than 7 megabases.

It can be performed with a single blood sample obtained from 10 weeks (gestational age), which is equivalent to being eight weeks pregnant.

Eurofins Biomnis in figures

As a French laboratory and European leader in specialised medical pathology testing, Eurofins Biomnis has been an expert in the new generation of DNA sequencing techniques for many years and has acquired extensive know-how in the areas of prenatal genetics and biology.

Experts in their fields, the qualified prenatal diagnostics biologists responsible for Ninalia NIPT at Eurofins Biomnis support prescribers, Laboratories and their patients in the implementation of this innovative genetic test.

1
century of expertise in specialised biology
32 000
medical biology tests every day
2 000
Karyotypes performed
in 2016
45 000
Ninalia tests performed
since october 2014
200 000
Maternal serum markers tests performed
in 2016

Home Home

Vous avez refusé de partager votre position.
Désolé. Nous n'arrivons pas à savoir où vous êtes...
Il faut nous autoriser à voir votre position...
Votre navigateur ne possède pas cette fonctionnalité.

Partner laboratories

out of laboratories in total out of laboratories in total